| Pfizer AG - Ibrance 75 mg, Hartkapseln | | 66138 | | 01 | | Ibrance 75 mg | | Hartkapseln | | L01EF01 | | | | 31.01.2017 | | |
| | Composition | | palbociclibum 75 mg, cellulosum microcristallinum, lactosum monohydricum 55.775 mg, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 172 (flavum), E 171, Drucktinte: lacca, E 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.28 mg. | | Packungsbestandteile | | Capsules | | | | | | BAG: Active Agent | Dose |
|---|
| | 75 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | Ammoniae Solutio | 28 | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | Drucktinte | | Lactose Monohydrate | 55.775 mg | | | | | | | Sodium | 1.28 mg | | | Per Centum | | | | | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Simeticone | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 21 | 1973.56 | 2162.80 | A | SL | No |
|
|
